Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response

Tools

Agirre, X, Fontalba, A, Andreu, EJ, Odero, MD, Larráyoz, MJ, Montiel, C ORCID: https://orcid.org/0000-0002-9144-8809, Calasanz, MJ, Fernández-Luna, JL and Prósper, F, 2003. Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response. Haematologica, 88 (12), pp. 1425-1426. ISSN 0390-6078

Full text not available from this repository.

Item Type:	Journal article
Description:	Letter to the editor
Publication Title:	Haematologica
Creators:	Agirre, X., Fontalba, A., Andreu, E.J., Odero, M.D., Larráyoz, M.J., Montiel, C., Calasanz, M.J., Fernández-Luna, J.L. and Prósper, F.
Publisher:	Ferrata Storti Foundation
Date:	2003
Volume:	88
Number:	12
ISSN:	0390-6078
Identifiers:	Number Type 1265382 Other
Divisions:	Schools > School of Science and Technology
Record created by:	Linda Sullivan
Date Added:	15 Jul 2021 16:04
Last Modified:	16 Jul 2021 07:45
Related URLs:	Publisher
URI:	https://irep.ntu.ac.uk/id/eprint/43494